Advertisement

Topics

Could Cytotoxic TILs Guide Treatment in Metastatic HER2+ Breast Cancer?

21:29 EDT 8 Aug 2017 | Cancer Networks

Low levels of cytotoxic stromal tumor-infiltrating lymphocytes are predictive of benefit derived from antibody- vs small molecule–based drug approaches to HER2-positive metastatic breast cancer.

Original Article: Could Cytotoxic TILs Guide Treatment in Metastatic HER2+ Breast Cancer?

NEXT ARTICLE

More From BioPortfolio on "Could Cytotoxic TILs Guide Treatment in Metastatic HER2+ Breast Cancer?"

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...